Desalting And Buffer Exchange System

Desalting And Buffer Exchange System Market Outlook

The global desalting and buffer exchange system market is projected to reach approximately USD 1.2 billion by 2035, growing at a CAGR of around 9.5% during the forecast period from 2025 to 2035. The expansion of this market is primarily driven by the increasing demand for protein purification processes in biopharmaceutical applications, coupled with the rising focus on advanced research activities within academic and research institutions. Additionally, the growing emphasis on drug discovery and development processes is prompting the adoption of desalting and buffer exchange systems, facilitating efficient purification and separation of biomolecules. Technological advancements in this sector, along with a surge in government funding for biotechnology research, are further fueling the growth of the market. These factors collectively contribute to the optimistic outlook for the desalting and buffer exchange system market over the next decade.

Growth Factor of the Market

Several factors are contributing to the robust growth of the desalting and buffer exchange system market. The escalating prevalence of chronic diseases is driving the need for innovative therapeutic solutions, necessitating effective protein purification and analysis techniques. Moreover, the biopharmaceutical sector is increasingly adopting various methods for efficient protein characterization, thereby boosting the demand for desalting systems. The advancements in desalting technology, including the introduction of high-throughput systems, are also attracting significant attention from researchers and companies alike, as these innovations enable faster and more efficient processing. Furthermore, the growing investment in biotechnology and pharmaceutical research is fostering a conducive environment for market growth, enhancing research capabilities and the development of novel therapeutic agents. Lastly, the increasing collaboration between academic institutions and industry players to develop new purification techniques is expected to propel the market forward.

Key Highlights of the Market

• Significant growth potential attributed to rising demand in biopharmaceutical applications.
• Technological innovations leading to advancements in purification methodologies.
• Growing emphasis on drug discovery and development processes.
• Increased funding in biotechnology research facilitating market expansion.
• Heightened collaborative efforts between academic institutions and the industry driving innovation.

By Product Type

Columns:

Columns represent a significant product type within the desalting and buffer exchange system market, primarily utilized for high-performance liquid chromatography (HPLC) applications. These columns are designed to effectively separate and purify proteins and other biomolecules based on their size or affinity. Their efficiency in providing tailored separation processes makes them an indispensable tool in both academic and industrial laboratories. The increasing adoption of HPLC methods for protein characterization is expected to elevate the demand for specialized columns in the coming years. Moreover, advancements in column technology, such as the development of monolithic columns, are further enhancing their performance and broadening their application range, thereby contributing positively to market growth.

Membranes:

Membranes are another critical product type in the desalting and buffer exchange system market, widely employed in ultrafiltration and dialysis processes. These membranes serve as selective barriers that facilitate the separation of solutes based on size, making them essential for various applications, including protein concentration and desalting. The growing need for rapid and efficient purification techniques is driving the adoption of membrane technologies. Innovations in membrane materials and configurations are also improving their effectiveness and durability, thus providing enhanced performance. As biopharmaceutical companies aim for higher yield and purity levels in their processes, the demand for membranes is expected to witness a significant upswing during the forecast period.

Resins:

Resins play a pivotal role in the desalting and buffer exchange system market, particularly in chromatographic applications. These materials are used for ion exchange and affinity purification, allowing for the selective capture of target proteins from complex mixtures. Resins offer significant advantages, such as high binding capacity and excellent selectivity, which are essential for achieving optimal purification outcomes. The growing trend of personalized medicine and targeted therapies is increasing the demand for high-performance resins in the biopharmaceutical sector. Furthermore, continuous innovations in resin technology, including the development of novel ligand chemistries, are expected to fuel market growth as they enhance purification efficiencies and broaden applications.

Kits:

Kits, comprising pre-assembled components designed for specific applications, are gaining traction in the desalting and buffer exchange system market. These kits allow researchers and lab technicians to conduct purification processes with minimal setup time and effort, thereby enhancing productivity in laboratory environments. The rising complexity of biological assays and experiments is driving the demand for user-friendly kits that ensure reproducibility and consistency. Additionally, the availability of kits for a wide range of applications, including protein and nucleic acid purification, is broadening their appeal across various sectors, including academia, clinical research, and pharmaceutical development, further contributing to market growth.

Instruments:

The instruments segment is integral to the desalting and buffer exchange system market, encompassing various devices used for purification and analysis. These include centrifuges, spectrophotometers, and chromatography systems, which are essential for executing effective purification protocols. The increasing focus on automation and high-throughput screening in research laboratories is propelling the demand for advanced instrumentation. Innovations in instrument design, such as the development of integrated systems that combine multiple functionalities, are enhancing efficiency and accuracy in purification processes. As the biopharmaceutical industry continues to evolve, the need for sophisticated instruments that can handle complex purification tasks is expected to drive significant growth in this segment.

By Application

Protein Purification:

Protein purification is a leading application driving the desalting and buffer exchange system market. With the increasing focus on biopharmaceuticals and biologics, the need for high-purity proteins is paramount for drug development and therapeutic applications. Desalting and buffer exchange processes are critical for removing contaminants and exchanging buffer solutions to prepare proteins for downstream applications. The rising prevalence of chronic diseases and the growing demand for monoclonal antibodies and recombinant proteins are further amplifying the need for efficient protein purification methods. As companies continue to invest in bioprocessing technologies, the protein purification application is anticipated to remain a significant growth driver in the market.

DNA Purification:

DNA purification is another critical application within the desalting and buffer exchange system market. The increasing utilization of molecular biology techniques and the growing need for reliable genetic analysis are propelling the demand for effective DNA purification methods. Desalting systems facilitate the removal of salts and other contaminants from DNA samples, ensuring high-quality results in applications such as PCR, sequencing, and cloning. The expansion of personalized medicine and genetic testing is further driving market growth in this segment, as researchers seek efficient methods for isolating and purifying DNA from various sources. Continuous advancements in purification techniques and the development of specialized kits for DNA purification are expected to support the growth of this application.

RNA Purification:

RNA purification is an emerging application that is gaining traction in the desalting and buffer exchange system market. The increased focus on RNA-based therapeutics, such as mRNA vaccines, and the growing interest in gene expression analysis are driving the demand for effective RNA purification methods. Desalting systems play a crucial role in preparing RNA samples for downstream applications by removing contaminants that may interfere with analyses. The expansion of research in the field of molecular biology and the need for high-quality RNA samples in diagnostics and therapeutic development are expected to contribute to the growth of RNA purification applications. As the biotechnology landscape evolves, RNA purification is set to become a key driver of market growth.

Drug Screening:

Drug screening applications are also contributing significantly to the desalting and buffer exchange system market. The pharmaceutical industry relies heavily on purification processes to evaluate the efficacy and safety of potential drug candidates during the drug discovery phase. Desalting systems are utilized to prepare compounds for high-throughput screening assays, ensuring that only the target compounds are analyzed. The ongoing advancements in drug discovery methodologies and the increasing investment in pharmaceutical research are propelling the demand for efficient drug screening processes. Furthermore, the trend toward personalized medicine, which requires tailored drug formulations, is expected to enhance the relevance of drug screening applications in the market.

Other:

In addition to the highlighted applications, several other uses drive the desalting and buffer exchange system market. These include applications in laboratory research, clinical diagnostics, and environmental testing, among others. The versatility of desalting and buffer exchange systems makes them suitable for a wide range of analytical procedures across various industries. As research continues to expand in fields such as proteomics and metabolomics, the demand for purification techniques that can effectively handle diverse analytes is expected to grow. The increasing adoption of desalting systems in various non-biopharmaceutical applications will likely contribute positively to the overall market dynamics.

By End User

Biopharmaceutical Companies:

Biopharmaceutical companies represent a significant end-user segment in the desalting and buffer exchange system market. These companies are primarily engaged in the development and manufacture of biologics, including monoclonal antibodies, vaccines, and recombinant proteins. The need for high-purity and well-characterized biomolecules is crucial for regulatory compliance and product efficacy. As biopharmaceutical companies invest heavily in research and development activities, the demand for efficient purification technologies is expected to rise. With the industry's continuous growth and the increasing complexity of biologics, the biopharmaceutical sector is anticipated to drive substantial demand for desalting and buffer exchange systems.

Academic & Research Institutes:

Academic and research institutes form a vital end-user segment in the desalting and buffer exchange system market. These institutions are at the forefront of scientific research and innovation, often focusing on the development of new therapeutic agents and biological research. The need for reliable purification processes is essential for producing high-quality samples for various studies, including protein interactions, enzymatic assays, and structural biology. The ongoing collaboration between academic institutions and industry players further supports the demand for advanced desalting and buffer exchange systems. As research capabilities continue to expand globally, the academic and research sector is expected to significantly contribute to market growth.

Contract Research Organizations:

Contract Research Organizations (CROs) play a crucial role as end users in the desalting and buffer exchange system market, providing specialized services to pharmaceutical and biotechnology companies. CROs are tasked with conducting various research and development activities, including preclinical studies, clinical trials, and analytical testing. The demand for efficient purification techniques is paramount for ensuring the quality and integrity of samples used in drug development. As the outsourcing trend continues to grow in the pharmaceutical industry, the reliance on CROs for specialized services will likely drive the demand for desalting and buffer exchange systems. The increasing number of CROs globally is expected to further enhance market growth.

Other:

Other end users of desalting and buffer exchange systems include various sectors such as clinical laboratories, diagnostic centers, and environmental research organizations. These entities utilize purification technologies for diverse applications, including clinical diagnostics, environmental monitoring, and food safety testing. The versatility of desalting systems allows them to cater to a wide range of analytical needs across multiple industries. As the demand for reliable testing and analysis continues to rise, the contribution of other end users to the market will become increasingly significant, further reinforcing the overall growth trajectory of the desalting and buffer exchange system market.

By Technique

Chromatography:

Chromatography is one of the primary techniques utilized in the desalting and buffer exchange system market. This method is essential for separating and purifying biomolecules based on their chemical and physical properties. Various chromatography techniques, such as ion exchange, affinity, and size exclusion chromatography, play a vital role in protein purification processes. As biopharmaceutical applications become more complex, the demand for advanced chromatographic techniques is expected to rise. The adoption of high-throughput chromatography systems is also facilitating faster and more efficient purification, which is crucial for meeting the growing needs of the industry. Overall, chromatography remains a cornerstone technique that significantly influences the desalting and buffer exchange system market.

Ultrafiltration:

Ultrafiltration is another critical technique in the desalting and buffer exchange system market, primarily employed for separating macromolecules based on size. This technique utilizes semi-permeable membranes to selectively allow smaller molecules and ions to pass through while retaining larger biomolecules. The increasing focus on protein concentration and purification, coupled with the need for efficient sample preparation, is driving the adoption of ultrafiltration methods. The versatility of ultrafiltration makes it suitable for various applications, including protein desalting and buffer exchange processes. As the demand for high-quality biomolecules in biopharmaceutical production increases, the role of ultrafiltration in the market will continue to expand.

Precipitation:

Precipitation is a traditional yet effective technique used in the desalting and buffer exchange system market for separating proteins and other biomolecules. This method involves adding precipitating agents to a solution, resulting in the formation of insoluble complexes that can be easily removed. Precipitation is particularly valuable for concentrating proteins and purifying them from complex mixtures. While this technique may not provide the same level of specificity as chromatography, its cost-effectiveness and simplicity make it a popular choice in various research applications. As biopharmaceutical companies seek efficient and economical purification methods, the precipitation technique is expected to maintain its relevance in the market.

Dialysis:

Dialysis is a widely used technique in the desalting and buffer exchange system market, particularly for the removal of small molecules and salts from protein solutions. This method employs a semi-permeable membrane to separate solutes based on size, allowing smaller contaminants to diffuse away from the target biomolecule. Dialysis is favored for its simplicity and effectiveness, making it a standard procedure in protein purification workflows. The growing trend towards biopharmaceutical production and research is driving the demand for dialysis systems, as researchers seek reliable methods for preparing samples for further analysis. As the need for high-quality biological samples increases, dialysis will continue to play a significant role in the desalting and buffer exchange system market.

By Region

The North American region is expected to dominate the desalting and buffer exchange system market, accounting for approximately 45% of the global market share by 2035. The region's leadership can be attributed to the presence of advanced biopharmaceutical companies, prominent academic and research institutions, and robust investment in biotechnology research and development. Additionally, the increasing prevalence of chronic diseases and the rising focus on personalized medicine in the United States are accelerating the demand for effective desalting and buffer exchange systems. Furthermore, the continuous advancements in purification technologies and the establishment of strategic partnerships between industry players are set to bolster market growth in North America. The CAGR for this region is projected to be around 10% during the forecast period, indicating robust growth potential.

In Europe, the desalting and buffer exchange system market is anticipated to follow closely behind North America, accounting for approximately 30% of the global market share. The region is characterized by a strong focus on pharmaceutical research and biotechnology innovation, particularly in countries such as Germany, the United Kingdom, and France. The increasing emphasis on drug development and the rising number of research collaborations are driving the demand for advanced purification technologies in this region. Furthermore, the growing trend of biopharmaceutical outsourcing to contract research organizations is expected to contribute positively to market growth in Europe. With a projected CAGR of 9% during the forecast period, the European market is poised for substantial growth.

Opportunities

The desalting and buffer exchange system market is poised to experience significant opportunities in the coming years, with advancements in technology being a key driver. As the demand for biopharmaceuticals continues to rise, particularly with the growing prevalence of chronic diseases, the need for efficient and reliable purification methods is becoming increasingly crucial. Companies are focusing on developing innovative desalting technologies, such as high-throughput systems and automated purification processes, that cater to the evolving needs of the biopharmaceutical industry. These advancements not only streamline workflows but also enhance the overall efficiency and yield of purification processes. Additionally, the rise of personalized medicine presents an opportunity for the desalting and buffer exchange market, as tailored therapeutic solutions require specialized purification techniques to ensure high-quality biomolecules.

Furthermore, the growing emphasis on environmental sustainability in research and production processes is opening up new avenues for market growth. Companies are increasingly adopting green chemistry principles and seeking eco-friendly alternatives in purification methods. This trend is catalyzing the development of biodegradable and reusable desalting materials, which align with the industry's shift towards sustainability. Moreover, the expansion of biobanks and the increasing demand for biorepositories are creating opportunities for desalting systems to play a vital role in sample preparation and preservation. As research into biomolecular interactions and therapeutic development continues to evolve, the desalting and buffer exchange system market is well-positioned to capitalize on these emerging opportunities.

Threats

Despite the favorable outlook for the desalting and buffer exchange system market, several threats could hinder growth. One significant concern is the intense competition among market players, leading to price wars and reduced profit margins. As numerous companies strive to capture market share, the pressure to lower prices may affect the quality of products and services offered in the market. This challenge is particularly acute for smaller players who may struggle to compete against established companies with extensive resources and established customer relationships. Additionally, the rapid pace of technological advancements necessitates continuous innovation and investment, which can pose a financial burden for companies that may not be able to keep up with the latest developments.

Another potential threat to the market is the regulatory landscape governing biopharmaceutical production and research. Stringent regulatory requirements and guidelines can complicate the approval processes for new purification technologies, leading to delays in product launches and increased compliance costs. Companies must navigate complex regulatory frameworks and invest considerable resources in ensuring that their systems meet the necessary standards. Moreover, the global supply chain disruptions caused by unforeseen events, such as pandemics or geopolitical tensions, can also impact the availability of essential components and materials required for desalting and buffer exchange processes. These factors collectively pose challenges that could hinder the growth of the desalting and buffer exchange system market.

Competitor Outlook

• GE Healthcare
• Thermo Fisher Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Agilent Technologies
• Waters Corporation
• PerkinElmer, Inc.
• Repligen Corporation
• MilliporeSigma
• VWR International
• Avantor, Inc.
• Fisher Scientific
• Eppendorf AG
• Sartorius AG
• Promega Corporation

The competitive landscape of the desalting and buffer exchange system market is characterized by the presence of several prominent players engaged in developing and providing innovative purification technologies. Leading companies, such as GE Healthcare and Thermo Fisher Scientific, leverage their extensive research and development capabilities to introduce cutting-edge desalting systems and purification methods that cater to the evolving needs of the biopharmaceutical industry. These companies often engage in strategic partnerships and collaborations to enhance their product offerings and expand their market reach. Moreover, the competitive environment is marked by ongoing mergers and acquisitions, as companies seek to bolster their portfolios and gain a competitive edge in the market.

In particular, Merck KGaA and Bio-Rad Laboratories are recognized for their commitment to innovation and quality in their desalting and buffer exchange systems. These companies invest heavily in R&D to develop new technologies that improve purification efficiencies and expand application areas. For example, Merck KGaA has introduced advanced resin technologies that enhance binding capacities, while Bio-Rad Laboratories has focused on developing user-friendly kits that streamline laboratory workflows. Additionally, Agilent Technologies and Waters Corporation, both key players in chromatography, are continuously enhancing their instruments and systems to meet the growing demand for high-performance purification solutions.

Furthermore, smaller players in the market, such as Repligen Corporation and MilliporeSigma, are making significant strides by focusing on niche markets and specialized applications. These companies often differentiate themselves by offering customized solutions tailored to specific research needs. The increasing importance of personalized medicine and the rise of biopharmaceutical outsourcing create opportunities for these players to carve out their market segments. As competition intensifies, companies will need to prioritize innovation, quality, and customer satisfaction to maintain their position in the desalting and buffer exchange system market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Eppendorf AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Avantor, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 MilliporeSigma
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fisher Scientific
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 PerkinElmer, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 VWR International
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Waters Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Promega Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Repligen Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Desalting And Buffer Exchange System Market, By End User
    • 6.1.1 Biopharmaceutical Companies
    • 6.1.2 Academic & Research Institutes
    • 6.1.3 Contract Research Organizations
    • 6.1.4 Other
  • 6.2 Desalting And Buffer Exchange System Market, By Technique
    • 6.2.1 Chromatography
    • 6.2.2 Ultrafiltration
    • 6.2.3 Precipitation
    • 6.2.4 Dialysis
  • 6.3 Desalting And Buffer Exchange System Market, By Application
    • 6.3.1 Protein Purification
    • 6.3.2 DNA Purification
    • 6.3.3 RNA Purification
    • 6.3.4 Drug Screening
    • 6.3.5 Other
  • 6.4 Desalting And Buffer Exchange System Market, By Product Type
    • 6.4.1 Columns
    • 6.4.2 Membranes
    • 6.4.3 Resins
    • 6.4.4 Kits
    • 6.4.5 Instruments

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Desalting And Buffer Exchange System Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Desalting And Buffer Exchange System market is categorized based on

By Product Type

• Columns
• Membranes
• Resins
• Kits
• Instruments

By Application

• Protein Purification
• DNA Purification
• RNA Purification
• Drug Screening
• Other

By End User

• Biopharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations
• Other

By Technique

• Chromatography
• Ultrafiltration
• Precipitation
• Dialysis

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GE Healthcare
• Thermo Fisher Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Agilent Technologies
• Waters Corporation
• PerkinElmer, Inc.
• Repligen Corporation
• MilliporeSigma
• VWR International
• Avantor, Inc.
• Fisher Scientific
• Eppendorf AG
• Sartorius AG
• Promega Corporation